Tudor Investment Corp’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-313
Closed -$238K 1427
2017
Q1
$238K Buy
313
+184
+143% +$146K 0.01% 1139
2016
Q4
$105K Buy
129
+39
+43% +$31K ﹤0.01% 1302
2016
Q3
$82K Sell
90
-84
-48% -$82.2K ﹤0.01% 1351
2016
Q2
$155K Buy
174
+50
+40% +$33.5K ﹤0.01% 1462
2016
Q1
$65K Hold
124
﹤0.01% 1641
2015
Q4
$74K Buy
124
+53
+75% +$38.4K ﹤0.01% 1556
2015
Q3
$45K Sell
71
-496
-87% -$377K ﹤0.01% 1480
2015
Q2
$513K Buy
+567
New +$634K 0.02% 760
2015
Q1
Sell
-50
Closed -$87K 1648
2014
Q4
$87K Sell
50
-77
-61% -$118K ﹤0.01% 1375
2014
Q3
$194K Buy
+127
New +$230K 0.01% 1207
2014
Q2
Sell
-74
Closed -$136K 1356
2014
Q1
$136K Buy
+74
New +$172K 0.01% 1096

Other funds holding VIVS

Tudor Investment Corp's VIVS Position: Q2 2017 in Review

Tudor Investment Corp sold out of VivoSim Labs (VIVS) in Q2 2017, closing a stake of 313 shares — an estimated $238K sold.

Tudor Investment Corp first reported a position in VIVS in Q1 2014 and held it in 11 quarters. The position peaked at $513K in Q2 2015. 117 funds tracked by Wall St. Rank hold VIVS as of Q2 2017.

  • Tudor Investment Corp reported no remaining VivoSim Labs position as of Q2 2017 after selling out during the quarter.
  • Tudor Investment Corp sold 313 VivoSim Labs shares in Q2 2017, an estimated $238K.
  • Tudor Investment Corp first reported a position in VivoSim Labs in Q1 2014 and held it in 11 quarters.
  • Tudor Investment Corp's VivoSim Labs position peaked at $513K in Q2 2015.
  • 117 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2017.

Based on Tudor Investment Corp's 13F filing for Q2 2017, filed 14 Aug 2017.